Registered Nurse in Newport, ME Accepting Medicare
6 Registered Nurse nurses found. Showing 1 - 6
 Catharine E Bennett, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 118 Moosehead Trl Ste 5, Newport, ME 04953 Phone: 207-368-5189 Fax: 207-368-4213 |
Elizabeth Ann Chipman, RN,BSN Registered Nurse - Home Health Medicare: Not Enrolled in Medicare Practice Location: 125 Elm St, Newport, ME 04953 Phone: 207-355-1406 |
Barbara A Day, RNC Registered Nurse - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 442 Moosehead Trl, Newport, ME 04953 Phone: 207-368-2072 Fax: 207-368-5290 |
 Mr. Kraig Michael Burbine, RN Registered Nurse - Case Management Medicare: Not Enrolled in Medicare Practice Location: 118 Moosehead Trl Ste 5, Newport, ME 04953 Phone: 207-368-5189 |
Kerry L Dow, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 118 Moosehead Trl Ste 5, Newport, ME 04953 Phone: 207-368-5189 Fax: 207-368-4213 |
Reita G Abbott, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 118 Moosehead Trl Ste 5, Newport, ME 04953 Phone: 207-368-5189 Fax: 207-368-4213 |
News Archive
NTSP Charitable Fund Board announces 2011 recipients of patient care grant funding opportunities
The North Texas Specialty Physicians (NTSP) Charitable Fund Board is pleased to announce the 2011 recipients of its patient care grant funding opportunities. The recipient organizations chosen serve the community and fit within the Charitable Fund's mission of "Driving innovations in the coordination and integration of safe and effective patient care in the North Texas Region."
New research suggests cell immortalization as more complicated process than originally thought
A mutation that helps make cells immortal is critical to the development of a tumor, but new research at the University of California, Berkeley suggests that becoming immortal is a more complicated process than originally thought.
Takeda, Affymax announce data from OMONTYS Phase 3 studies on anemia due to CKD
Affymax, Inc. and Takeda Pharmaceuticals U.S.A., Inc. (TPUSA) today announced the presentation of post-hoc sub-group analyses of the EMERALD Phase 3 studies that evaluated OMONTYS (peginesatide) Injection, an erythropoiesis-stimulating agent (ESA), for the treatment of anemia due to chronic kidney disease (CKD) in adult dialysis patients.
Study identifies gap between theory and reality of dispensing medication
A study published in the journal Applied Ergonomics compared the standardized processes set out for community pharmacists to follow when dispending medication to what happens in reality. A gap was revealed and researchers also looked at the reasons for this.
› Verified 4 days ago
Nurse Practitioner
Registered Nurse
Physician Assistant
Licensed Practical Nurse